The RING finger ubiquitin ligase Siah2 controls the stability of various substrates involved in stress and hypoxia responses, including the prolyl hydroxylase 3 (PHD3), which is controlling the stability of HIF1α. In the present study we determined the role of Siah2 phosphorylation in the regulation of its activity towards PHD3. We show that Siah2 is subject to phosphorylation by p38 MAPK, which increases Siah2-mediated degradation of PHD3.
Regulation of protein stability is largely mediated by ubiquitin ligases, which mark their substrates for efficient proteasome-dependent degradation (1) . The conjugation of ubiquitin moieties to substrates requires coordinated action of the ubiquitinactivating enzyme (E1), the ubiquitin conjugating enzyme E2 and the E3 ligase, which associates with the substrate and thereby determines the specificity in degradation of various substrates (2) . Among the major types of E3 ligases are the RING finger proteins, which contain a characteristic cysteine-rich zinc binding domain defined by a pattern of conserved cysteine and histidine residues, and catalyze polyubiquitination (3) . Characteristic of RING finger ubiquitin ligases is their ability to mediate degradation of their substrates, as well as their own availability, by promoting their own ubiquitination-dependent degradation (4) . Siah is a member of the RING finger E3 ligases, which was originally identified and characterized in Drosophila as sina (seven in absentia) and was shown to affect degradation of Tramtrack, a transcriptional repressor of the R7 cell's fate during eye development (5, 6) . Siah2-dependent degradation was reported for over a dozen substrates including the transcriptional coactivator (OBF-1; 6), nuclear receptor co-repressor (N-CoR; 7), the signaling regulatory module for JNK, p38 and IKK, TRAF2 (8) , the anti-apoptosis protein (BAG-1;9), the surface receptor DCC (10) , the cdk activator RINGO/speedy (11) the KREBS cycle regulatory protein α−keto-glutarate-dehydrogenase (12) and the rate-limiting factor in HIF1α stability, prolyl-hydroxylase 3 (PHD3) (13, 14) .
Utilizing oxygen and 2-oxoglutarate as co-factors, PHD's hydroxylate HIF-1α in normoxia and mild (physiological) hypoxia condition (15) . Hydroxylation of HIF-1α is prerequisite to its association with the von Hippel-Landau tumor suppressor gene product (pVHL), which results in HIF1α ubiquitination and subsequent proteasomedependent degradation (16, 17) . Through these substrates, Siah2 affects major cellular regulatory processes such as those affecting stress kinases, cell cycle distribution, transcriptional control and apoptosis. In most cases Siah2 activity is associated with cellular stress, suggesting its role as a stress-activated ligase.
Siah2's own activity is subject to extensive regulation. At the RNA level, Siah2 transcription is increased upon changes in oxygen tension, as was shown in mild hypoxia (13) . At the protein level, Siah2 is subject to extensive self (auto)-ubiquitination, which limits its availability under certain conditions (17) . Further, Siah2 activity as an ubiquitin ligase requires cooperation with adaptor proteins. Siah interacting protein (SIP) was shown to be important in regulation of Siah2 ligase activity towards β-catenin (18) . More recent studies pointed to the role of another adaptor protein, POSH, in regulation of Siah2 activity along the JNK signaling pathway (19) . These observations point to the tight regulation of Siah2 activity.
Whereas the role of post-translational modification in regulation of substrate recognition by E3 ligases is well documented, only a handful cases have demonstrated the role of ligase phosphorylation in regulation of its activity. Among those, the E3 ligase Itch was phosphorylated by JNK-1 after T cell receptor engagement that enhanced its enzymatic activity (20) . In contrast, Nedd4-2 was found to be phosphorylated by serum glucocorticoid-inducible protein kinase 1 (SGK-1) and thereby inactivated (21) . Here we demonstrate that phosphorylation of Siah2 by p38, a MAPK activated by cytokines, ROS, and DNA damage, as well as hypoxia, increases its effect on PHD3.
Experimental Procedures
Cell Culture and Reagents: HeLa cells, wild-type mouse embryonic fibroblasts (MEFs) and p38-/-MEFs and MKK3/6 -/-MEFs were maintained in Dulbecco's modified Eagle's medium supplemented with fetal bovine serum (10%) and 100 µg/ml penicillin/streptomycin. 293T cells were maintained in Dulbecco's modified Eagle's medium supplemented with bovine serum (10%) and antibiotics. Cell cultures were maintained at 37ºC in 5% CO 2 . Various kinase inhibitors were purchased from Calbiochem. Recombinant active p38 MAPK alpha was purchased from Upstate Inc. Antibodies against Flag epitope, phosphop38 MAPK, anti-β actin and anti-α tubulin were purchased from Sigma. Anti-HA antibody, antip38 MAPK was purchased from Santa Cruz. Anti-HIF1 alpha antibody was purchased from Novus Biologicals. Polyclonal anti-HIF-1α antibody was a generous gift from Dr. Gary Chiang.
Lipofectamine Plus reagent was purchased from Invitrogen. Cells were maintained under hypoxia using an invivo 2 Hypoxia 400 workstation from Biotrace International Inc.
Plasmids and Transfection-
The following mutants were generated with the indicated primers in site directed mutagenesis (quick change) using Siah2 plasmid as template: Siah2 T24A (primer 5'CCGCCGCCGCCTCAGGCCCCGCACGCCC CGTCC and antisense), Siah2 S29A (primer 5' 5'GGACGGGGCGTGCGGGGCCTGAGGCGGC GGCGG and its antisense), Siah2 T24A S29A (primer 5'CCGCACGCCCCGGCCCCGGCTGC GCCC and antisense), Siah2 S29D (primer 5'CCGCACGCCCCGGACCCGGCTGCGCCC and antisense), Siah2 T24ES29D (primer 5'CCGCCGCCTCAGGAACCGCACGCCCCGG ACCCGGCTGCGCCC and antisense), Siah2 S69A (primer 5'GGGGCCGACCCGGTGGCCC CGCAGCACCACGAG and antisense), Siah2 T120A (primer 5'TGCAGGGGCGCCCTAG CGCCCAGCATCAGGAAC and antisense), Siah2 D-mut-HA (R272A, R273A, R274A) (primers 5'GAGTTGAATGGGAACGCGGCGG CACTGACCTGGGAGGCC and antisense). All mutations were confirmed by DNA sequencing. GST-Siah2 and its phospho mutants were expressed in Escherichia coli BL21 and purified using immobilized glutathione beads as described previously (8) . 293T cells were transfected using the calcium phosphate precipitation method. HeLa, NIH3T3, and MEF cells were transfected with Lipofectamine PLUS reagent.
In Vitro Ubiquitination Assay -In vitro translated 35 S-labelled Siah2-HA was subjected to one or three rounds of phosphorylation with recombinant p38 MAPK (or mock phosphorylation) followed by an in vitro ubiquitination assay in ubiquitination buffer (50 mM Tris-HCl, pH 8.0, 5 mM MgCl 2 , 0.5 mM dithiothreitol, 2 mM NaF, and 3 µM okadaic acid) supplemented with purified HA-ubiquitin (0.5 µg), 2 mM ATP, E1 (Affinity Research, Exeter, UK), purified E2 (UbcH5b) (0.5 µg), and/or purified Siah2 for 25 min at 37 °C. Reaction mixtures were then separated on 7% SDS-PAGE followed by western immunoblotting with anti-HA antibody.
Immunoblotting-Cells were lysed using lysis buffer containing 350mM NaCl, 0.25% NP-40, 1mM EDTA, 1mM EGTA, 1mM DTT, 1mM glycerol phosphate, 1mM sodium orthovanadate and 30% glycerol with protease inhibitor mixture (Sigma). Protein concentrations were determined using Coomassie protein assay reagent (Pierce). Proteins were boiled in SDS-sample buffer and separated on SDS-PAGE. Proteins were transferred onto a nitrocellulose membrane. The blots were blocked with 5% non-fat dry milk in TBST (50mM Tris-Cl, pH 8.0, 10mM NaCl, and 0.1% Tween-20) at room temperature for 1h followed by incubation with the indicated antibodies at 4°C overnight, followed by washes in TBST and incubation with either anti-mouse or anti-rabbit secondary antibody tagged to a fluorophore emitting at either 680nm or 800nm (Amersham Biosciences) for 1h at room temperature. Immunoprecipitation was performed by incubating 1.0mg of proteins with 1µg of anti-FLAG or anti-HA or anti-Siah2 antibodies overnight and then further incubating them for 2h with 20µl of protein G beads (Invitrogen). Beads were washed three times with lysis buffer, and proteins were solubilized in 2x Laemmli buffer and subjected to western blot analysis as detailed above. Following washes in TBST, blots were visualized using a Li-COR machine and analyzed using the Odyssey (v. 2.0) software which was also used for quantification, as indicated under the respective blots.
In vitro p38 MAP kinase assay: GST-Siah2 was incubated with active recombinant p38 MAPKα (20ng) in the presence of reaction buffer containing 12mM Tris-HCl (pH 7.5, 0.1mM EGTA), supplemented with 1µCi [γ 32 P] ATP diluted in 40 mM MgCl 2 and 250mM ATP. Reaction was carried out at 30°C for 15min. The reaction was stopped by adding Laemmeli buffer and samples were then boiled and subjected to SDS-PAGE analysis. Phosphorylation of substrates was measured by autoradiography. In some experiments (i.e. Fig. 2B ) p38 MAPK was immunoprecipitated from treated or untreated cell lysates was used as a source of enzyme and GST-ATF2 (aa 1-105) was used as a substrate.
Phosphopeptide analysis: In vivo
32 P metabolic labeling: WT-MEFs and p38 KO MEFs were transfected with Rm-Siah2 and 24h later incubated with phosphate-free medium containing 10% dialyzed fetal bovine serum for 2h. The medium was removed and reconstituted with 4 mCi/ml of [ 32 P] orthophosphate and added to cells followed by hypoxia treatment for 4h. Cells were washed and harvested. Cell lysates were then subjected to immunoprecipitation with anti-Flag antibody followed by SDS-PAGE analysis. 1µg of recombinant Siah2 proteins were phosphorylated by recombinant p38 kinase in the presence of 10 µCi [γ-32 P]ATP in kinase buffer as described (22) , resolved by SDS PAGE, and transferred to nitrocellulose. Radiolabeled Siah2 was excised and analyzed by tryptic peptide mapping using the protocol of Luo and co-workers (23) .
Immunofluorescence microscopy-Transfected or untransfected cells grown on glass cover slips were fixed with 3% paraformaldehyde and 2% sucrose in PBS for 20min at room temperature and washed twice with PBS, followed by incubation for 5 min in permeabilization buffer (0.3% Triton X-100, 3mM MgCl 2 , and 6.8% sucrose). After blocking the cells with 3% bovine serum albumin/PBS for 30min, cells were incubated with anti-HA antibody (1:100) for 1h, washed, and further incubated with fluorescein isothiocyanatelabeled secondary antibody (1:500 dilutions) for 1h. Cover slips were inverted and mounted on slides with Vectashield containing DAPI and affixed with nail polish. Fluorescence was monitored using a fluorescence microscope (IX71; Olympus).
Results

Siah2 enhances degradation of PHD3 in hypoxia and is phosphorylated by p38 MAPK in vitro.
To determine the effect of hypoxia on Siah2-mediated degradation of PHD3, MEF cells were co-transfected with Siah2-HA and PHD3-Flag followed by growth under normoxia (21%) or hypoxia (1%). Immunoblot analysis revealed that Siah2-dependent degradation of PHD3 is more pronounced under hypoxia (Fig. 1A) . The effect of Siah2 on PHD3 degradation was concomitantly seen at the level of HIF-1α which inversely correlated with that of PHD3. These data are consistent with our earlier finding that Siah2 targets PHD3 for degradation and that Siah2's effect on PHD3 is better seen in hypoxia (12, 13) . Since hypoxia triggers activation of several protein kinases implicated in the hypoxia response, we sought to determine whether Siah2 activity increases in hypoxia could be attributed to altered phosphorylation by a hypoxia-activated kinase. To this end, we compared the effects of pharmacological inhibitors of major signaling pathways on Siah2-mediated degradation of PHD3. Inhibition of PKC did not have a major effect on altered the degree of PHD3 degradation by Siah2 (Fig. 1B) . Inhibition of PI3K slightly increased Siah2-mediated degradation of PHD3 (Fig. 1B) . In contrast, inhibition of p38 MAPK and ERK-1/-2 attenuated Siah2 activity in both normoxia and hypoxia (Fig. 1C) . To test whether p38MAPK and ERK can directly phosphorylate Siah2, we carried out in vitro kinase reactions using purified bacterially produced and recombinant p38 MAPK alpha and ERK-2. These assays revealed that whereas ERK did not phosphorylate Siah2 (data not shown), p38 efficiently phosphorylated Siah2 but not PHD3 in vitro (Fig.1D ). These data suggest that Siah2 is phosphorylated by p38 and provide the initial indication that such phosphorylation affects Siah2 activity. Subsequent studies therefore focused on the role of p38 MAPK in Siah2 phosphorylation.
Hypoxia activates p38 MAPK and stabilizes HIF-1α in a p38 MAPK-dependent manner.
To assess the relevance of p38 to the hypoxia response, we assessed possible changes in the activity of p38 MAPK during hypoxia. Hypoxia treatment (for 2h or 6h) resulted in activation of p38 MAPK, which coincided with stabilization of HIF-1α. The relation between p38 activation in hypoxia and stabilization of HIF1α was demonstrated by using the pharmacological inhibitor of p38, which abolished HIF-1α stability ( Fig. 2A) . This observation is consistent with earlier reports that linked p38 to stabilization of HIF1α (24, 25) . Of note, inhibition of p38 activity also caused a mild increase in PHD3 levels ( Fig.  2A) , which is compatible with the predicted effect of p38 on Siah2 activity and consequently PHD3 stability. The activation of p38 MAPK by hypoxia was further confirmed by immunokinase assays in which p38 was immunoprecipitated from hypoxiatreated cells used for the in vitro kinase reaction of GST-ATF2. Of note, the degree of p38 activation was lower than seen upon treatment with UVirradiation (Fig. 2b) . Additional confirmation of the role of p38 in Siah2 phosphorylation came from in vivo labeling experiments in which cells were metabolically labeled with 32 Porthophosphate, followed by immunoprecipitation and analysis of exogenously expressed Siah2 (RING mutant was used in these experiments to allow sufficient accumulation of Siah2 since WT Siah2 is subject to an extensive degree of autoubiquitination and degradation, even when expressed as an exogenous protein). Immunoprecipitation of Siah2 followed by autoradiography revealed its phosphorylation in cells after hypoxia treatment; such phosphorylation was abolished after exposure to the p38 pharmacological inhibitor (SB203580; 5μM, which specifically affects p38 kinases) (Fig.  2C ). Further support for the role of p38 in Siah2 phosphorylation comes from the analysis of p38 KO MEFs in which Siah2 phosphorylation was vastly attenuated (Fig. 2C ). These data establish that Siah2 is a substrate for p38 MAPK and that its phosphorylation by p38 is induced in hypoxia.
p38 phosphorylation of its substrates was often shown to require association through a conserved D-domain containing a docking site as shown for MKP-1, MKP-2, MKK1, MKK7 and PAC-1 ( Fig  S1) . Siah2 sequence analysis identified such a docking site, which is conserved among mouse, human and Xenopus Siah2 (Fig. S1) . To test the possible importance of the D domain for p38 association and phosphorylation of Siah2, we mutated key residues within this domain (arg272, arg273 arg274 were converted to ala; Siah2-Dmut). Expression of WT or D-domain-mutant Siah2 revealed that association with p38 is impaired in the D-mutant form (Fig. 2D) . Consistent with this observation, kinase reactions using recombinant p38α as a kinase and bacterially produced and purified WT or Ddomain-mutant Siah2 as substrates revealed that the phosphorylation of the D-domain-mutant form of Siah2 was reduced, compared with phosphorylation of the WT protein by p38 (Fig.  2E ). These data suggest that p38's association is important for its phosphorylation of Siah2.
p38 MAPK phosphorylates Siah2 at Threonine 24 and Serine 29.
To identify putative sites for Siah2 phosphorylation of p38, we performed phosphopeptide mapping analysis of GST-Siah2. This analysis identified several peptides phosphorylated in vitro by p38 (Fig. 3A) . On the basis of the relative position of the phosphorylated peptides we predicted possible phosphorylation on amino terminal residues of Siah2, which were likely to include T24 and S29. To determine whether these are indeed the sites of p38 phosphorylation of Siah2, we monitored change in the peptides phosphorylated on mutant Siah2, using GST-Siah2-T24A, GST-Siah2-S29A and GST-Siah2-T24A/S29A. This analysis revealed that both T24 and S29 on Siah2 are phosphorylation sites for p38 MAPK, as mutation of either site caused the loss of the corresponding peptides (Fig. 3A) . Significantly, the double mutant form of Siah2 was no longer phosphorylated by p38 (Fig. 3A) . We can not exclude the possibility that Siah2 may be subject to phosphorylation on other MAPK acceptor sites which is below the detection limits under the experimental conditions used here. Further confirmation of the peptide mapping results was obtained upon comparison of all possible p38 phosphorylation sites on Siah2. Mutation of Siah2 on threonine 24 and serine 29 to alanine decreased phosphorylation of Siah2 by p38 MAPK, whereas mutation of serine 69 or threonine 120 did not affect the degree of p38 phosphorylation (Fig. 3B) . Consistent with the peptide mapping analysis, mutation on both threonine 24 and serine 29 abolished p38-mediated phosphorylation of GST-Siah2 (Fig. 3C) . These data suggest that threonine 24 and serine 29 are the primary sites of phosphorylation on Siah2 by p38 MAPK.
Serine 29 mutation on Siah2 attenuates its ability to degrade PHD3.
To determine the possible role of Siah2 phosphorylation by p38, we monitored in vitro ubiquitination of Siah2 (self ubiquitination) in vitro and its ability to cause PHD3 degradation in vivo. To this end in vitro translated Siah2-HA was subjected to 1 or 3 rounds of phosphorylation (thereby resulting in a low and a highly phosphorylated forms of Siah2) using recombinant p38, followed by analysis of self ubiquitination in vitro. As shown in Fig. 4A , in vitro ubiquitination of Siah2 was not affected upon its phosphorylation by p38. These data indicate that p38 phosphorylation is not required for its E3 ubiquitin ligase activity per se, as reflected here by its degree of auto-ubiquitination.
To assess possible effects of Siah2 phosphorylation on the degradation of PHD3, we transfected NIH3T3 cells with Siah2-HA, Siah2-T24A-HA or Siah2-S29A-HA together with PHD3-Flag. Immunoblot analysis revealed efficient degradation of PHD3 by the WT and the T24A mutant form of Siah2, whereas the S29A mutant of Siah2 was less efficient in mediating PHD3 degradation (Fig. 4B) . These data suggest that S29 may be more important in Siah2's ability to mediate PHD3 degradation. To confirm this possibility, we generated and tested the E3 ligase activity of a phosphomimic mutant of S29 by mutating it into a negatively charged residue, aspartic acid. Siah2-S29D activity was compared with that of WT and of mutant S29A using PHD3 as a substrate. This analysis revealed that Siah2S29D was more efficient in degradation of PHD3 than the WT Siah2 (Fig. 4C) . To verify the effect of WT and mutant forms of Siah2 on degradation of endogenous PHD3, we utilized HeLa cells, which express higher levels of endogenous PHD3. Basal levels of endogenous PHD3 increases under hypoxia (Fig 4D, compare  lanes 1 and 2) due to HIF1α-dependent increase in PHD3 transcription (26) . Consistent with the changes seen in exogenously expressed PHD3, expression of Siah2-S29A-HA did not affect PHD3 stability whereas the phospho-mimic mutant Siah2-S29D was more efficient than WT Siah2 in degrading PHD3 (Fig. 4D, compare lanes  2,4,6,8, respectively) .
Siah2-dependent degradation of PHD3 is impaired in MKK3/6 DKO cells.
To provide direct support for the role of p38 in regulating Siah2 activity towards PHD3 degradation, we used MEFs obtained from MKK3/6 mice, which lacks p38's upstream kinases (27) . To this end, WT and MKK3/6 double KO MEFs were co-transfected with Siah2 and PHD3 and the changes in PHD3 stability were analyzed in normoxia and hypoxia. Whereas in WT MEFs Siah2-mediated degradation of PHD3 was seen in normoxia and further increased in hypoxia, such increases were attenuated in MKK3/6 DKO MEFs (Fig. 4E ). These data provide genetic support for the role of p38 MAPK in Siah2-dependent degradation of PHD3.
Effect of phosphomutant Siah2 on HIF-1α stabilization
We next compared Siah2-HA, Siah2 T24A-HA, Siah2 S29A and Siah2 T24AS29A-HA for their ability to degrade PHD3. Whereas Siah2-HA and Siah2 T24A degrades PHD3 efficiently, Siah2 S29A-HA and Siah2 T24AS29A-HA were not effective (Fig 5A) . To further assess the consequences of differential degradation of PHD3 by phosphomutant and phosphomimetic Siah2-HA for HIF-1α, 293T cells were transfected with Siah2-HA, Siah2 mutated on both phosphoacceptor sites (T24A/S29A-HA) and PHD3-Flag and subsequently subjected to normoxia or hypoxia. Analysis of HIF-1α stability revealed that hypoxia (5%) induced stabilization of HIF-1α, and that such stabilization was increased further upon exogenous expression of WT Siah2, but to a lesser degree upon expression of Siah2 mutated on both p38 phosphoacceptor sites (Fig. 5B) . In contrast, HIF1α levels induced by hypoxia were further elevated upon expression of the phosphomimic mutant of Siah2, which coincided with effective degradation of endogenous PHD3 (Fig. 5C ). These data reveal that elevated expression of Siah2 contributes to stabilization of HIF-1α  under hypoxia, and that the phosphorylation of Siah2 by p38 on T24S29 is important for the Siah2-dependent effect on both PHD3 and consequently HIF1α under hypoxia.
PHD3 association with Siah2 is affected by p38 phosphorylation.
In earlier studies we demonstrated that PHD3 associates with Siah2 and that this association is mediated by the C-terminal domain of PHD3 (14) . Since this association is prerequisite for Siah2's ability to ubiquitinate PHD3, which results in its degradation by the proteasome, we monitored possible changes in the association between WT and phosphomutant forms of Siah2 and PHD3. Expression of Siah2-HA, Siah2-T24A/S29A-HA and PHD3-Flag in 293T cells revealed that phosphomutant Siah2 exhibits lower association with PHD3, compared with the WT form (Fig. 6A) . The association between WT Siah2 and PHD3 was reduced following hypoxia (due to degradation of PHD3 by Siah2) whereas it remained unchanged in the case of the phosphomutant form of Siah2, evidently because of impaired E3 ligase activity, which requires p38 phosphorylation in response to hypoxia treatment. Under the same conditions, Siah2 mutated on both phosphoacceptors sites lost most of its ability to cause degradation of PHD3 (Fig 6B) . Similar analysis of the phosphomimic form of Siah2 revealed its ability to elicit increased PHD3 degradation compared with the WT form of Siah2 (Fig. 6C) .
Thus, we next monitored the interaction between PHD3, Siah2-T24A/S29A-HA and Siah2-T24ES29D-HA in the presence of proteasome inhibitor. Treatment with lactacystin increased the degree of PHD3 association with WT and phosphomutant forms of Siah2, although in both cases relative binding of the phosphomutant form of Siah2 was noticeably reduced (Fig. 6D) . Unlike the reduced association with phosphomutants, binding with the phosphomimic form of Siah2 was indistinguishable from the WT form of Siah2 and was enhanced by addition of proteasome inhibitor (Fig. 6D) . These data suggest that phosphorylation of Siah2 on threonine 24 and serine 29 is important for its binding with PHD3.
Phosphorylation of Siah2 by p38 affects its subcellular localization. Given the changes in the association of phosphomutant Siah2 and PHD3, we tested the possibility that phosphorylation of Siah2 affects its subcellular localization, which would contribute to lesser association. HeLa cells were transfected with Siah2-HA, Siah2 T24AS29A-HA and Siah2 T24ES29D-HA and subjected to immunofluorescence microscopy using anti-HA antibody to detect Siah2 and its phosphomutants. Both the WT and phosphomutant (Siah2-T24AS29A-HA) forms of Siah2 were found in both nuclear and cytosolic fractions; however, the phosphomimic form of Siah2 (Siah2-T24ES29D-HA) was predominantly found within the perinuclear region (Fig. 7A ). These data suggest that phosphorylation of Siah2 on T24/S29 results in its exclusion from the nucleus and that its activity after such modification may be enhanced towards proteins that colocalize within this fraction.
To further determine whether changes in Siah2 localization upon its phosphomimic mutation can be attributed to export from the nucleus, we tested possible changes in localization of Siah2 after treatment with Leptomycin B (LMB), a nuclear export inhibitor. LMB caused accumulation of both Siah2-HA and Siah2-HA T24E/S29D-HA in the nucleus (Fig. 7B and 7C ). This finding suggests that localization of Siah2-T24E/S29D within the perinuclear region is due to active export from the nucleus, suggesting that p38 phosphorylation of Siah2 facilitates its export from the nucleus.
We next determined which of the Siah2 forms colocalizes with PHD3. As expected, WT Siah2 colocalized with PHD3, primarily within the nuclei (Fig. 7D, upper panel) . However, Siah2 mutated on its phosphoacceptor sites did not colocalize with PHD3, despite the fact that both proteins are located within the nuclei, suggesting that subnuclear localization is important for Siah2-PHD3 interaction. Surprisingly, phosphomimic of Siah2 did not colocalize with PHD3, as it retained its perinuclear staining while PHD3 retained its nuclear staining (Fig. 7D middle panel) . Since our biochemical data revealed increased binding between Siah2 and PHD3 following lactacystin treatment, we further tested their localization when proteasome activity is inhibited, therefore increasing the possibility for capturing association between PHD3 and Siah2 prior to degradation of PHD3. In the presence of lactacystin Siah2-HA co-localizes with PHD3 in the nucleus and cytosol to a greater degree than seen with Siah2 T24AS29A-HA (Fig. 7E ) Co-localization pattern of phosphomimic Siah2 with PHD3 was found to be increased following exposure with lactacystin, similar to what was seen with the WT, which is consistent with our biochemical findings. These data suggest that selective subnuclear localizations are required for Siah2 ability to cause degradation of PHD3, and that the constitutive signal for export of Siah2 to the cytosol, as seen for the phosphomimic Siah2, suffice to cause efficient degradation of PHD3 within the nuclei prior to its export to the cytoplasm. These data further confirm the importance of Siah2 phosphorylation in the regulation of its subcellular localization and degradation of PHD3.
Effect of UV-irradiation on PHD3 degradation by
Siah2. Since p38 is activated by diverse stress stimuli we have tested the impact of UV irradiation, a potent activator of p38 (Fig. 2B) , on Siah2-dependent degradation of PHD3. To this end 293T cells were co-transfected with Siah2-HA and PHD3-Flag followed by mock or UV treatment. Siah2 ability to reduce the level of PHD3 was less pronounced after UV treatment (Fig. S2) . The lower impact of Siah2 on degradation of PHD3 after UV exposure can be attributed to additional changes elicited by this treatment on Siah2 or PHD3 protein. Indeed, UVirradiation causes increase in expression of exogenous PHD3, which can be attenuated upon expression of Siah2 (Fig. S3) . Inhibition of p38 activity by dominant negative form did not affect the level of PHD3 expression, implying that the level of PHD3 following UV-irradiation is less affected by p38 (Fig. S4) . The effect of Siah2 on PHD3 degradation is distinct from its effect on TRAF2 degradation which is enhanced following UV-irradiation ( Fig. S5 and Ref 28 ). These data suggest that p38 phosphorylation of Siah2 is important but not always sufficient for determining the overall level of its substrates.
Discussion
The regulation of E3 ligases is central in the control of their ability to ubiquitinate their substrates. Such regulation has been shown to include modification by deubiquitinating enzymes, sumoylation and association with scaffold proteins as well as partner RING finger proteins. It is therefore surprising that only a handful reports address the role of phosphorylation of ubiquitin ligases. In the present study we demonstrate that phosphorylation of Siah2 on T24 and S29 is mediated by p38 MAPK and that such phosphorylation increases Siah2 activity towards PHD3 and consequently towards the levels of HIF1α. Our findings are consistent with the report that HIF1α stabilization in hypoxia is dependent on p38 kinases as MKK3/6 DKO cells exhibit impaired level of HIF1α expression (24) .
The notion that p38 is important for Siah2 activity towards degradation of PHD3 are explained by the effect of p38 on (i) subcellular localization of Siah2 (ii) Siah2's affinity to PHD3. That phosphorylation of an ubiquitin ligase can alter its subcellular localization has been shown for Mdm2, which is phosphorylated by PKB/AKT to result in its localization in the nucleus (29) . In the case of Siah2 such phosphorylation causes its exclusion from the nucleus and its localization in the perinuclear region, as revealed by the phosphomimic form of Siah2. However, colocalization with PHD3 was primarily seen with the WT and not with the phosphomutant form of Siah2. Of note, co-localization of PHD3 with the phosphomimic form as well as with the WT but not phosphomutant form of Siah2 was seen in the nuclear domain upon treatment of cells with proteasome inhibitor, suggesting that Siah2 effect on PHD3 is carried out within the nuclear domain. This observation, in conjunction with our biochemical data indicating strong association and efficient degradation of PHD3 by phosphomimic Siah2 suggest that (a) Siah2 mediated PHD3 degradation is taking place within defined subnuclear fractions (since phosphomutant Siah2 which generally localized within the nuclei did not colocalize with PHD3), and (b) p38 phosphorylation of Siah2 causes its nuclear exclusion following its degradation of PHD3 in the nucleus.
Since Siah2 substrates are both nuclear and cytosolic, such exclusion is expected to affect the selectivity of Siah2 towards its substrates. Preliminary data suggest that the Nuclear Corepressor NCoR, which is among the nuclear substrates for Siah2, is less affected by Siah2 mutated to resemble phosphorylation by p38 than by Siah2 mutated on these phosphoacceptor sites, suggesting that substrate recognition can be affected by phosphorylation-dependent localization of the Siah2 protein, and perhaps serving as a molecular switch to determine the substrate specificity. Along these lines, our study revealed that p38 phosphorylation of Siah2 takes place in response to hypoxia but also following cytokine (TNFα) stimuli or UV-irradiation. Surprisingly, the activation of p38 under each of these conditions does not imply increased efficiency in the degradation of PHD3 following each of these stimuli. As found for UV-irradiation, Siah2 dependent degradation of PHD3 is less efficient, when compared with hypoxia response, probably due to additional changes elicited by UV-irradiation on the ligase or the substrate. Kinetics and efficiency of Siah2 degradation of its substrates is expected to vary depending other modifications, localization and activity of Siah2 and its substrates.
It is possible that phosphorylation on Siah2 can be also mediated by other stress kinases, including JNK, which are equally capable of phosphorylating similar phosphorylation motifs. Consistent with this possibility is the notion that different forms of stress cause Siah2 phosphorylation by different MAPK, which would be expected to have equal impact on its localization and kinase activity. Common to MAPK substrates is the D-domain, which is also found on Siah2 and which serves as a docking site for different members of the MAPK family (30) . Such a domain is usually required for p38 association-dependent phosphorylation and possible translocation from one cellular compartment to another. Given the analysis performed with leptomycin B, we conclude that p38 phosphorylation is likely to occur within the nucleus and to promote the export of the phosphorylated ligase to the cytosol, where it concentrates along the perinuclear region.
Constitutive activation of Siah2 by p38 is expected to increase in its degradation of PHD3 with consequential stabilization of HIF1α. "Hypoxia like phenotypes", where HIF1α is stabilized under normoxic conditions, were reported in cases where there is constitutively active AKT signaling (associated with Pten mutation in tumors; 31), suggesting that additional signals are required for stabilization of HIF1α in addition to increased Siah2 phosphorylation. The latter coincides with the observation that AKT also contributes to transcriptional activation of Siah2 (our unpublished data), suggesting that both transcription and phosphorylation of Siah2 are required for mediating an impact on PHD3 sufficient to result in HIF1α stabilization.
Of the two sites phosphorylated by p38, S29 appears to have greater impact on Siah2's ability to elicit degradation of PHD3. However, since T24 mutation also decreased Siah2 phosphorylation it is plausible that phosphorylation of T24 regulates the degree or duration of S29 phosphorylation rather than the changes in Siah2 localization and ligase activity. Phosphorylation of adjacent sites has been reported for several substrates. Often an initial phosphorylation recruits regulatory proteins that alter conformation of the substrate, in turn enabling phosphorylation on a second site, as shown for c-myc phosphorylation on S58/62 sites (32), or c-Jun phosphorylation by GSK3β (33).
In all, the present study provides new insight into regulation of Siah2 activity through its phosphorylation by p38 MAPK. Such regulation offers another layer in the regulation of Siah2 by its interacting proteins POSH and SIP. One would expect that in concert with p38 phosphorylation Siah2 may be subjected to phosphorylation by different kinases, possible control by protein phosphatases, other post-translational modifications, and the activity of deubiquitinating enzymes.
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We thank Angel Nebrada for providing us with p38KO cells, David Bowtell for antibodies against Siah2, and Bob Abraham and Gary Chiang for providing us with the antibodies to HIF1α. We thank members of the Ronai lab for advice and discussions. Support by NCI grant (RO1-CA111515) to ZR is gratefully acknowledged. 10µM and 20µM, 4h) and PI3K inhibitor (LY294002, 25µM and 50µM, 4h) .C, 293T cells were transfected with Siah2-Flag and PHD3-Flag as indicated. Cells were either left untreated or treated with 1% hypoxia for 4h in presence or absence of p38 MAPK (SB203580, 5µM for 4h) and ERK inhibitors (U0126, 20µM for 4h). Cell lysates were subjected to immunoblot analysis using anti-Flag, anti-HA and anti-GFP antibodies. D, In vitro kinase assay: Bacterially purified GST-Siah2, GST-PHD3 and GST-ATF2 were incubated with active recombinant p38α in the presence of γ-P 32 ATP for 15min. The reaction mixture was than subjected to SDS PAGE analysis. Phosphorylation of substrates was monitored by autoradiography. Fig. 2 Hypoxia induces p38 MAPK activity and Siah2 phosphorylation. A, MEFs were subjected to 1% hypoxia for the indicated time intervals in the absence or presence of SB203580 (5µM) and cell lysates were subjected to immunoblot analysis using anti-HIF-1α, anti-phospho p38 MAPK, anti-p38 MAPK, anti-PHD3 and anti-β actin antibodies. B, MEFs were treated with 1% hypoxia and UV (40J/m 2 ) for the indicated time intervals. P38 MAPK was immunoprecipitated and an in vitro kinase assay was performed using GST-ATF2 as a substrate in the presence of γ-P32 ATP. Phosphorylation of ATF2 was monitored by autoradiography and p38 levels were detected by immunoblotting with anti-p38 MAPK antibody. C, Wild type (WT) MEFs and P38 knock-out (KO) MEFs were transfected with RING mutant (Rm) Siah2-Flag. 48h later cells were subjected to 1% hypoxia in the absence or presence of p38 MAPK inhibitor, SB203580 for 4h in the presence of 32 P-orthophosphate as indicated. Cells were harvested and lysates were immunoprecipitated with anti-Flag antibody and subjected to SDS PAGE analysis. Phosphorylation was monitored by autoradiography followed by immunoblotting with anti-Flag antibody. Cell lysates from WT MEFs and p38 KO MEFs were subjected to immunoblot analysis using anti-p38 MAPK antibody. D, 293T cells were transfected with Siah2-HA, Siah2-D mut-HA mutant and p38 MAPK-Flag. Cell lysates were subjected to immunoprecipitation with anti-HA antibody followed by immunoblotting with anti-Flag antibody and anti-HA antibody respectively. Total cell lysates were also subjected to analysis using antibodies to Flag to monitor p38 MAPK levels. E, GST-Siah2 and a GST-Siah2-D mut-HA mutant were subjected to an in vitro kinase assay using recombinant p38 MAPK, followed by SDS-PAGE analysis. Phosphorylation of Siah2 was monitored by autoradiography. Fig. 3 Phosphopeptide mapping for Siah2 phosphorylation by p38 A,. GST-Siah2 and point mutants GST-Siah2-T24A, GST-Siah2 S29A and GST-Siah2 T24AS29A were phosphorylated in vitro using active recombinant p38 MAPK and then subjected to tryptic digestion. Peptides were separated by chromatography and phosphorylation was monitored by autoradiography. B, GST-Siah2 and GST-Siah2 which were mutated on Threonine 24, Serine 69, Serine120 to Alanine were subjected to an in vitro kinase assay using recombinant p38 MAPK in the presence of γ-P 32 ATP. the reaction mixture was than subjected to SDS PAGE analysis and Siah2 phosphorylation was monitored by autoradiography. C, Analysis was performed similar to that shown in panel B, except that single or double phosphomutant of Siah2 were used. 35 S-labeled Siah2-HA was subjected to in vitro kinase assay (or control mock reaction) using recombinant p38 MAPK and either cold or [γ 32 P] ATP once (lane5) or three times (lane6). Reaction mixture was washed extensively and subjected to an in vitro ubiquitination reaction in the presence of E1, E2 (UbcH5c) and Ub-HA for 25 min at 37°C. The reaction mixture was then separated on SDS-PAGE, and ubiquitination of GST-Siah2 was monitored by immunoblots with anti-HA antibody. Degree of phosphorylation was monitored by autoradiograph and total levels of GST-Siah2 are shown (middle panel). Levels of Siah2-HA was monitored by immunoblot analysis with anti-HA antibody (lower panel). B, NIH3T3 cells were transfected with Siah2-HA, Siah2 T24A-HA, Siah2S29A-HA and PHD3-Flag. Cell lysates were subjected to immunoblot analysis and probed with the antibodies indicated in Figure. C, 293T cells were co-transfected with 1µg or 2µg of Siah2-HA, Siah2 S29A-HA, Siah2 S29D-HA and PHD3-Flag. Cell lysates were subjected to immunoblot analysis and probed with anti-Flag, anti-HA and β-actin antibodies. D, HeLa cells were transfected with Siah2-HA, Siah2S29A-HA and Siah2S29D-HA. Cells were either left untreated or treated with 1% hypoxia. Cell lysates were subjected to immunoblot analysis and probed with anti-PHD3, anti-HA and anti-β actin antibodies. E, WT MEFs and MKK3/6 knock-out MEFs were transfected with PHD3-Flag and various amounts (µg) of Siah2-HA as indicated. 48h later cells were either untreated or treated with 1% hypoxia for 4h. Cell lysates were subjected to immunoblot analysis using anti-Flag antibody and anti-β actin antibody. Cell lysates were subjected to immunoprecipitation with anti-HA antibody followed by immunoblot analysis with anti-Flag antibody followed by anti-HA antibody. B, 293T cells were transfected with Siah-HA, double phosphomutant Siah2T24AS29A-HA and PHD3-Flag. Cells were either left untreated or treated with 1% hypoxia. Cell lysates were subjected to immunoblot analysis with anti-Flag, anti-HA and anti-GFP antibodies. C, 293T cells were transfected with Siah2-HA, double phosphomimetic mutant Siah2T24ES29D-HA and PHD3-Flag. Cell lysates were subjected to immunoblot analysis with anti-Flag, anti-HA and anti-β actin antibodies. D, 293T cells were transfected with Siah2-HA, Siah2 T24AS29A-HA and Siah2 T24ES29D-HA and PHD3-Flag. Cell lysates were prepared after treatment with 20µM lactacystin (4h) or control mock treatment followed by immunoprecipitation with anti-HA antibody and immunoblot analysis using anti-Flag and anti-HA antibodies. Cell lysates were subjected to immunoblotting and probed with anti-Flag, anti-HA, and anti-β actin antibodies. and Siah2 T24ES29D-HA (panel C). Cells were treated with nuclear export inhibitor, LMB (100nM) for 3h as indicated. Cells were fixed and subjected to immunofluorescence with anti-HA antibody. D, Cells were transfected with the indicated HA-Siah2 WT and mutant forms and Flag PHD3 and processed for Immunostaining using antibodies to HA (green) or Flag (red). Representative pictures are shown for each antibody as well as their overlay. E, Cells were transfected with Siah2-HA, SiahT24S29A-HA, Siah2 T24ES29D-HA and Flag PHD3 and were treated with 20µM lactacystin for 4h. Cells were then processed for immunostaining using antibodies to HA (green) or Flag (red). Representative pictures are shown for each antibody as well as their overlay.
Supplemental Figures
S1: p38 docking sites. Sequence alignment reveals p38 docking sites (underlined) in known p38 MAPK substrates and Siah2.
S2: UV-irradiation attenuates Siah2-mediated degradation of PHD3. 293T cells were transfected with Siah2-HA and PHD3-Flag. 48 h later cells were mock or UV treated (40J/m 2 ) and harvested at the indicated time points (h). Cell lysates were then subjected to immunoblotting with anti-Flag, anti-HA, or anti-β actin antibodies.
S3: UV-irradiation increases PHD3 stability, which is attenuated by Siah2. Experiment was performed as detailed in S2 and analysis was carried out with the indicated antibodies.
S4:
Inhibition of p38 does not affect degree of Siah2-mediated degradation of PHD3. 293T cells were transfected with Siah2-HA, p38 MAPK-ASP-Flag (dominant negative) and PHD3-Flag. 48 h later cells were either mock or UV-treated (40J/m 2 ) and harvested after 1h. Cell lysates were then subjected to immunoblotting and probed with anti-Flag, anti-HA, or anti-β actin antibodies.
S5:
UV-irradiation induces Siah2 dependent degradation of TRAF2. Experiment was performed as detailed in S2 except TRAF2 was transfected instead of PHD3; analysis was carried out with the indicated antibodies.
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